Alys Pharmaceuticals
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
100 Northern Ave, Boston, Massachusetts,...Website
www.alyspharma.comRevenue
$5.6 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Alys Pharmaceuticals
Based in Boston, Massachusetts, Alys Pharmaceuticals is a biotechnology company with a focus on immuno-dermatology.Explore more
Alys Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Alys Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Alys Pharmaceuticals recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Alys Pharmaceuticals
Check if Alys Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Alys Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Alys Pharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Alys Pharmaceuticals has new funding data
Check out if Alys Pharmaceuticals is spiking on competitors!
Click to see if Alys Pharmaceuticals had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Alys Pharmaceuticals as Masked Content
Find 2 more new buyers
Compare Similar Companies to Alys Pharmaceuticals
Compare insights from companies similar to Alys Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Alys Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Alys Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Alys Pharmaceuticals.
Alys Pharmaceuticals financials insights
Gather financial insights about Alys Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Other Financing Round
$100M
Most Recent Scoops
Project
Product Development, Product Management, Legal Affairs, Governmental Affairs & Regulation, Medical Research, Pharmaceuticals, Clinical Operations, Regulations
Project
Product Development, Product Management, Legal Affairs, Governmental Affairs & Regulation, Medical Research, Pharmaceuticals, Clinical Operations, Regulations
Funding
Funding
Funding
Alys Pharmaceuticals News & Media
Alys Pharmaceuticals announces CTA submission for ALY-301, the first mast cell selective c-Kit inhibitor for treatment of Cold Urticaria
ALY-301 is a first-in-class bispecific antibody targeting c-Kit and CD-203c with mast cell selectivity Designed to enable safe dosing in chronic conditions and deliver clinical proof-of concept in a Phase 1/1b study BOSTON and LAUSANNE, Switzerland, June 10, 2025 /PRNewswire/ -- Alys...Alys Pharmaceuticals Announces Dosing of First Patient in Phase IIa Trial of ALY-101 for Alopecia Areata
Unique siRNA platform, developed with Nobel Prize Laureate Craig Mello, offers potential for treating multiple dermatology indications ALY-101 is formulated as an intradermal injectable for the treatment of Alopecia Areata Health Authorities in Canada and the United States provided swift...Alys Pharmaceuticals receives IND clearance for Phase 2a trial of first genetic medicine program in dermatology
ALY-101 is an intradermal injectable JAK1 siRNA-lipid conjugate for the treatment of Alopecia Areata Significant progress made in advancing the Alys pipeline following $100m seed financing from Medicxi BOSTON and LAUSANNE, Switzerland, Feb. 4, 2025 /PRNewswire/ -- Alys Pharmaceuticals,...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Alys Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Based in Boston, Massachusetts, Alys Pharmaceuticals is a biotechnology company with a focus on immuno-dermatology.... Read More
